Key result
Noninvasive myocardial and mechanical efficiency metrics improve cardiovascular risk stratification and outcome prediction.
Why the study?
The need for invasive data historically limited human studies of myocardial efficiency, but noninvasive PET and echocardiography have prompted renewed interest in understanding these parameters across cardiovascular states.
The transition from invasive to noninvasive assessments of myocardial and mechanical efficiency offers a promising avenue for improving risk stratification and guiding therapy across a wide spectrum of cardiovascular diseases.
Efficiency metrics may aid risk stratification in HF and valvular disease; extends noninvasive methods but leaves open prospective outcome trials.
Myocardial work and oxygen consumption (MVO 2 ) are tightly coupled. The patient's physiological state, presence of disease, heart rate, and microvascular control of oxygen delivery all combine to maintain this relationship. The myocardial efficiency (MyoEff) of the heart is determined by the ratio of stroke‐work (SW) divided by MVO 2 , whereas mechanical efficiency (ME) is derived from the left ventricular pressure‐volume loop construct and is the ratio of SW to pressure‐volume area. The need to collect invasive data limited the ability to perform human studies, but the development of noninvasive tools such as positron emission tomography (PET) combined with echocardiography led to a resurgence in this field of study. We summarize the current understanding of the significance of MyoEff and ME as outcomes predictors after aortic valve replacement and as parameters in cardiovascular health, highlighting their potential for improving risk stratification and guiding prophylactic interventions.
No takes yet. Share an insight, caveat, or question.
Pierson et al. (2026) conducted a review in Cardiovascular disease (e.g., heart failure, aortic stenosis, hypertension). Assessment of myocardial and mechanical efficiency was evaluated. Myocardial and mechanical efficiency, increasingly assessed noninvasively via PET and echocardiography, serve as important parameters for tracking cardiovascular health, predicting outcomes, and improving risk stratification across multiple disease states.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: